METASTATIC NEUROENDOCRINE CARCINOMA
Clinical trials for METASTATIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail shows promise against rare, aggressive cancer
Disease control OngoingThis study tested a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in 17 people with advanced, poorly differentiated neuroendocrine cancer that had spread. The goal was to see if the treatment could shrink tumors or stop them from growing. The approach combine…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:22 UTC
-
New combo shows promise for tough cancers
Disease control OngoingThis study tests a combination of two drugs—nivolumab (an immunotherapy that helps the immune system fight cancer) and temozolomide (a chemotherapy drug)—in people with small-cell lung cancer that has returned or stopped responding to treatment, or advanced neuroendocrine tumors.…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 15, 2026 11:54 UTC